Neoplasms, Advanced
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001) (NCT02731742) | Merck Sharp & Dohme LLC | 2016-06-22 |
| Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies (NCT00246103) | H. Lee Moffitt Cancer Center and Research Institute | 2004-03-01 |
Track Neoplasms, Advanced automatically
Every clearance here is in the API, with alerts when new ones post.